ANESTHETIZED RABBIT AS A MODEL FOR ISCHEMIA-INDUCED AND REPERFUSION-INDUCED ARRHYTHMIAS - EFFECTS OF QUINIDINE AND BRETYLIUM

被引：28

作者：

COKER, SJ

机构：

来源：

JOURNAL OF PHARMACOLOGICAL METHODS | 1989年 / 21卷 / 04期

关键词：

D O I：

10.1016/0160-5402(89)90064-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：263 / 279

页数：17

相关论文

共 23 条

[1] ALLAN G, 1987, BRIT J PHARMACOL, V88, P333
[2] REPERFUSION VENTRICULAR TACHYARRHYTHMIAS - CORRELATION WITH ANTECEDENT CORONARY-ARTERY OCCLUSION TACHYARRHYTHMIAS AND DURATION OF MYOCARDIAL ISCHEMIA
BALKE, CW
KAPLINSKY, E
MICHELSON, EL
NAITO, M
DREIFUS, LS
[J]. AMERICAN HEART JOURNAL, 1981, 101 (04) : 449 - 456
[3] ACUTE CORONARY-ARTERY OCCLUSION-REPERFUSION-INDUCED ARRHYTHMIAS IN RATS, DOGS AND PIGS - ANTIARRHYTHMIC EVALUATION OF QUINIDINE, PROCAINAMIDE AND LIDOCAINE
BERGEY, JL
NOCELLA, K
MCCALLUM, JD
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 81 (02) : 205 - 216
[4] FACTORS THAT DETERMINE THE OCCURRENCE OF ARRHYTHMIAS DURING ACUTE MYOCARDIAL-ISCHEMIA
BOLLI, R
FISHER, DJ
ENTMAN, ML
[J]. AMERICAN HEART JOURNAL, 1986, 111 (02) : 261 - 270
[5] CORONARY-ARTERY LIGATION IN ANESTHETIZED RATS AS A METHOD FOR THE PRODUCTION OF EXPERIMENTAL DYSRHYTHMIAS AND FOR THE DETERMINATION OF INFARCT SIZE
CLARK, C
FOREMAN, MI
KANE, KA
MCDONALD, FM
PARRATT, JR
[J]. JOURNAL OF PHARMACOLOGICAL METHODS, 1980, 3 (04): : 357 - 368
[6] COKER S J, 1987, British Journal of Pharmacology, V90, p21P
[7] NIFEDIPINE REDUCES ARRHYTHMIAS BUT DOES NOT ALTER PROSTANOID RELEASE DURING CORONARY-ARTERY OCCLUSION AND REPERFUSION IN ANESTHETIZED GREYHOUNDS
COKER, SJ
PARRATT, JR
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) : 406 - 417
[8] CONNELLY C, 1982, AM J PHYSIOL, V243, pH682, DOI 10.1152/ajpheart.1982.243.5.H682
[9] REDUCTION OF ACUTE MYOCARDIAL ISCHEMIA IN RABBIT HEARTS BY NAFAZATROM
FIEDLER, VB
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (02) : 318 - 324
[10] IMPORTANCE OF INTERACTION WITH ADRENERGIC-NEURONS FOR ANTIFIBRILLATORY ACTION OF BRETYLIUM IN THE DOG
FRAME, VB
WANG, HH
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (02) : 336 - 345